drugset / Trial / NCT00963027

Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

NCT00963027

Phase 1 Completed 30 enrolled United Therapeutics
CrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of esomeprazole, a proton pump inhibitor, on treprostinil pharmacokinetics.

Timeline

Start
2009-09
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral
Subject Treprostinil diethanolamine Unknown 1 mg Oral